Evidence map›Paper›PMID 26758733›Full record

Observational studyHeart and vessels2016

Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.

Hideki Miyachi, Atsushi Takagi, Katsumi Miyauchi, Masao Yamasaki, Hiroyuki Tanaka, Masatomo Yoshikawa, Mike Saji, Makoto Suzuki, Takeshi Yamamoto, Wataru Shimizu and 2 more

Open access · hybridFull text readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Heart and vessels, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Roles of microRNAs in the Cardiovascular System.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Hideki MiyachiTokyo CCU Network Scientific Committee, Tokyo, Japan. hidep-@nms.ac.jp.
Atsushi TakagiTokyo CCU Network Scientific Committee, Tokyo, Japan.
Katsumi MiyauchiTokyo CCU Network Scientific Committee, Tokyo, Japan.
Masao YamasakiTokyo CCU Network Scientific Committee, Tokyo, Japan.
Hiroyuki TanakaTokyo CCU Network Scientific Committee, Tokyo, Japan.
Masatomo YoshikawaTokyo CCU Network Scientific Committee, Tokyo, Japan.
Mike SajiTokyo CCU Network Scientific Committee, Tokyo, Japan.
Makoto SuzukiTokyo CCU Network Scientific Committee, Tokyo, Japan.
Takeshi YamamotoTokyo CCU Network Scientific Committee, Tokyo, Japan.
Wataru ShimizuDepartment of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.
Ken NagaoTokyo CCU Network Scientific Committee, Tokyo, Japan.
Morimasa TakayamaTokyo CCU Network Scientific Committee, Tokyo, Japan.
Shibuya University Network · JPNippon Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Limited data exists on ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) managed by a well-organized cardiac care network in a metropolitan area. We analyzed the Tokyo CCU network database in 2009-2010. Of 4329 acute myocardial infarction (AMI) patients including STEMI (n = 3202) and NSTEMI (n = 1127), percutaneous coronary intervention (PCI) was performed in 88.8 % of STEMI and 70.4 % of NSTEMI patients. Mean onset-to-door and door-to-balloon times in STEMI patients were shorter than those in NSTEMI patients (167 vs 233 and 60 vs 145 min, respectively, p < 0.001). Coronary artery bypass graft surgery was performed in 4.2 % of STEMI and 11.4 % of NSTEMI patients. In-hospital mortality was significantly higher in STEMI patients than NSTEMI patients (7.7 vs 5.1 %, p < 0.007). Independent correlates of in-hospital mortality were advanced age, low blood pressure, and high Killip classification, statin-treated dyslipidemia and PCI within 24 h were favorable predictors for STEMI. High Killip classification, high heart rate, and hemodialysis were significant predictors of in-hospital mortality, whereas statin-treated dyslipidemia was the only favorable predictor for NSTEMI. In conclusion, patients with MI received PCI frequently (83.5 %) and promptly (door-to-balloon time; 66 min), and had favorable in-hospital prognosis (in-hospital mortality; 7.0 %). In addition to traditional predictors of in-hospital death, statin-treated dyslipidemia was a favorable predictor of in-hospital mortality for STEMI and NSTEMI patients, whereas hemodialysis was the strongest predictor for NSTEMI patients.

Indexed as

Coronary Artery BypassDelivery of Health Care, IntegratedPercutaneous Coronary InterventionUrban Health ServicesAgedAged, 80 and overChi-Square DistributionCoronary AngiographyDyslipidemiasFemaleHospital MortalityHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLogistic ModelsMaleMiddle AgedHydroxymethylglutaryl-CoA Reductase InhibitorsIn-hospital mortalityNon-ST elevation myocardial infarctionRisk factorsST elevation myocardial infarction

Identifiers

PMID26758733
PMCPMC5085984
OpenAlexW2235529519

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.